As CSF Tau has become an essential index for diagnosis of AD and other tauopathologies (Blennow and Zetterberg 2018; Takashima et al. 2019), clinical realities, such as manifestations, should be considered in differential diagnosis. Here, MAPT is linked to Alzheimer disease.